Section 12.2 (Part 2)
Table 12.3 Requirements for conventional blood typing reagents| Antibody specificity | Specification | Performance evaluation
As a minimum, two examples of the following reference cells should be included* | Batch release testing |
|---|
| Specificity | Potency |
|---|
| Positive reactors | Negative reactors |
|---|
| Cell type | No. | Cell type | No. | Cell type | No. |
|---|
| Anti-A | Normally blue coloured
Should equal or exceed potency of reference preparation(s)
Should detect variants and subgroups as detailed in the manufacturer's instructions for use | Ax,A3 | A1 | 2 | B | 2 | A1 | 1 |
| A cord cells | A2B | 2 | O | 2 | A2B | 2 |
| | Ax* | | | | | |
| Anti-B | Normally yellow coloured
Should equal or exceed potency of reference preparation(s)
Should detect variants and subgroups as detailed in the manufacturer's instructions for use | Bx, B3, Bv | B | 2 | A1 | 2 | B | 1 |
| B cord cells | A1B | 2 | O | 2 | A1B | 2 |
| Anti-A,B | Normally clear coloured
Should equal or exceed potency of reference preparation(s)
Should detect variants and subgroups as detailed in the manufacturer's instructions for use | A1,A2, B, A1B, A2B | A1 | 1 | O | 4 | A1 | 1 |
| Ax,A3 | A2 | 2 | | | A2 | 2 |
| Bx, B3 | B | 2 | | | B | 2 |
| A and B cord cells | Ax | 2 | | | | |
| Anti-A1 | Normally clear coloured
Should equal or exceed potency of reference preparation(s)
Should detect variants and subgroups as detailed in the manufacturer's instructions for use | | A1 | 2 | A2 | 2 | A1 | 2 |
| | A1B | 2 | A2B | 2 | | |
| | | | B | 2 | | |
| | | | O | 2 | | |
| Anti-D | Normally clear coloured
Should equal or exceed potency of reference preparation(s)
Should detect variants and subgroups as detailed in the manufacturer's instructions for use | Weak D (500 sites/cell) | R1r | 2 | r'r | 1 | R1r | 2 |
| Cw,Cx | R2r | 2 | r''r | 1 | | |
| DVI type 1, DVI type 3, DIV, DV, DVII, DFR, DBT, ROHAR | Weak D* | 2 | rr | 1 | | |
| Anti-C | Normally clear coloured
Potency titre greater than 4 vs by techniques detailed in manufacturer's instructions for use
Should detect variants and subgroups as detailed in the manufacturer's instructions for use | Cw, Cx, r'S | R1r | 1 | R2R2 | 1 | R1r | 2 |
| R2RZ | R1R2 | 2 | r''r | 1 | | |
| | r'r | 1 | rr | 1 | | |
| Anti-E | Normally clear coloured
Potency titre greater than 4 vs by techniques detailed in manufacturer's instructions for use
Should detect variants and subgroups as detailed in the manufacturer's instructions for use | R1RZ | R2r | 1 | R1R1 | 1 | R2r | 2 |
| EW | R1R2 | 2 | r'r | 1 | | |
| | r''r | 1 | rr | 1 | | |
| Anti-c | Normally clear coloured
Potency titre greater than 4 vs by techniques detailed in the manufacturer's instructions for use
Should detect variants and subgroups as detailed in the manufacturer's instructions for use | R1RZ, R1wR1 | R1r | 2 | R1R1 | 3 | R1r | 2 |
| | R1R2 | 1 | | | | |
| | r'r | 1 | | | | |
| Anti-e | Normally clear coloured
Potency titre greater than 4 vs by techniques detailed in the manufacturer's instructions for use
Should detect variants and subgroups as detailed in the manufacturer's instructions for use | R2RZ | R2r | 2 | R2R2 | 3 | R2r | 2 |
| | R1R2 | 1 | | | | |
| | r''r | 1 | | | | |
| Anti-Cw | Normally clear coloured
Potency titre greater than 4 vs by techniques detailed in the manufacturer's instructions for use | R1wR1,r'wr,R1wr | R1wr or | 2 | R1r | 1 | R1wr | 2 |
| | R1wR2 | 2 | R1R1 | 1 | | |
| | r'wr | 1 | r'r | 1 | | |